These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9483561)

  • 1. Effects of quinpirole on central dopamine systems in sensitized and non-sensitized rats.
    Sullivan RM; Talangbayan H; Einat H; Szechtman H
    Neuroscience; 1998 Apr; 83(3):781-9. PubMed ID: 9483561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function.
    Escobar AP; Cornejo FA; Olivares-Costa M; González M; Fuentealba JA; Gysling K; España RA; Andrés ME
    J Neurochem; 2015 Sep; 134(6):1081-90. PubMed ID: 26112331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens.
    Del Arco A; Mora F; Mohammed AH; Fuxe K
    J Neural Transm (Vienna); 2007 Feb; 114(2):185-93. PubMed ID: 16897609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow.
    Koeltzow TE; Austin JD; Vezina P
    Neuropharmacology; 2003 Jan; 44(1):102-10. PubMed ID: 12559127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated exposure to cocaine alters medial prefrontal cortex dopamine D₂-like receptor modulation of glutamate and dopamine neurotransmission within the mesocorticolimbic system.
    Liu K; Steketee JD
    J Neurochem; 2011 Oct; 119(2):332-41. PubMed ID: 21692802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition.
    Culver KE; Rosenfeld JM; Szechtman H
    Neuropharmacology; 2002 Sep; 43(3):385-93. PubMed ID: 12243768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens.
    Yamada H; Kuroki T; Nakahara T; Hashimoto K; Tsutsumi T; Hirano M; Maeda H
    Brain Res; 2007 Feb; 1131(1):88-96. PubMed ID: 17169339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent nicotine sensitization and effects of nicotine on accumbal dopamine release in a rodent model of increased dopamine D2 receptor sensitivity.
    Perna MK; Brown RW
    Behav Brain Res; 2013 Apr; 242():102-9. PubMed ID: 23291224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.
    Maple AM; Perna MK; Parlaman JP; Stanwood GD; Brown RW
    Eur J Neurosci; 2007 Nov; 26(9):2532-8. PubMed ID: 17970732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
    Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.
    Culver KE; Szechtman H; Levant B
    Eur J Pharmacol; 2008 Sep; 592(1-3):67-72. PubMed ID: 18644362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats.
    Culver KE; Rosenfeld JM; Szechtman H
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):202-10. PubMed ID: 10972466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic involvement in medial prefrontal cortex and core of the nucleus accumbens in the regulation of ethanol self-administration: a dual-site microinjection study in the rat.
    Samson HH; Chappell A
    Physiol Behav; 2003 Sep; 79(4-5):581-90. PubMed ID: 12954398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats.
    Escobar AP; González MP; Meza RC; Noches V; Henny P; Gysling K; España RA; Fuentealba JA; Andrés ME
    Int J Neuropsychopharmacol; 2017 Aug; 20(8):660-669. PubMed ID: 28531297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunohistochemical examination of the effects of sensitisation on the mesotelencephalic dopaminergic response to d-amphetamine.
    Phillips GD; Setzu E; Vugler A; Hitchcott PK
    Neuroscience; 2003; 117(3):741-53. PubMed ID: 12617978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
    Perreault ML; Seeman P; Szechtman H
    Behav Neurosci; 2007 Oct; 121(5):976-91. PubMed ID: 17907829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain.
    Uehara T; Tanii Y; Sumiyoshi T; Kurachi M
    Brain Res; 2000 Mar; 860(1-2):77-86. PubMed ID: 10727625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.